Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Overall, medical weight loss with semaglutide offers a clinically proven, sustainable approach to weight loss, providing individuals with a tool to effectively manage their weight while improving their overall health and quality of life
Semaglutide has been shown to reduce the risk of type 2 diabetes, lower blood pressure, and improve cholesterol levels
Prime Peptides Provider Profile Name: Prime Peptides Website: primepeptides.co Provider Type: Research Peptide Vendor FDA Warning Letter: December 2024 Operating Details E-commerce peptide vendor Products explicitly labeled for Research Purposes only and not intended for human use No prescription required for purchase Sells semaglutide, tirzepatide, BPC-157, TB-500, GHK-Cu, and other research peptides Received an FDA warning letter in December 2024 regarding the sale of unapproved drugs Accepts credit card and cryptocurrency About the Company Prime Peptides describes its semaglutide as a synthetic analog of the GLP-1 hormone used in research to study glucose regulation and insulin secretion, intended for research purposes only, specifically noting it is designed for Research Purposes only and not for human use
As its use has expanded, questions have emerged about potential side effects, including concerns about semaglutide and blood clots
